All posts from Annabelle
Annabelle in Group,

Major Chart Support Approaches On Cara Therapeutics (CARA)

This past Friday saw a 40% collapse in shares of Cara Therapeutics Inc (NASDAQ:CARA). The culprit was poor drug trial results for one of their main drug candidates. Smart investors stayed away from the massive collapse on Friday aside from quick scalps. However, there is a swing trade level approaching quickly based off chart support. The level to buy for a multi-day bounce is $14.25. Investors can expect a potential bounce of 20% off this level.